Earth is headed toward several catastrophic climate 'tipping points,' study warns
Earth is headed toward several catastrophic climate 'tipping points,' study warns
Show Caption
Hide Caption
Could the ocean be our solution to climate change?
Ocean alkalinity enhancement, if scaled up, could make a meaningful difference in fighting global warming.
The climate keeps changing, despite the Trump administration's attempt to silence the entire phenomenon.
A new study out April 23 reports that the world is on course to trigger several climate "tipping points" if policies stay on their current course.
These points of no return are specific moments when the planet has warmed so much that certain effects become irreversible.
Scientists assessed the risk of 'tipping' in 16 different parts of the Earth system – ranging from the collapse of major ice sheets to the "dieback" of tropical coral reefs and vast forests.
'Climate tipping points could have devastating consequences for humanity," said study co-author Tim Lenton, from the University of Exeter's Global Systems Institute in the United Kingdom. "It is clear that we are currently on a dangerous trajectory – with tipping points likely to be triggered unless we change course rapidly."
What is a 'tipping point'?
A 'tipping point' occurs when a small change tips a system into a new state, causing significant and long-term transformation. The debate about tipping points in the climate system has intensified over the past two decades, according to the study.
What are some of the tipping points?
Tipping points mentioned in the study include collapse of the Greenland and Antarctic ice sheets; coral-reef die-offs; Amazon rainforest loss; lack of winter sea ice in the Arctic; abrupt permafrost thaw; mountain glacier loss; and collapse of a key Atlantic current that could affect climate worldwide.
Trump administration takes aim at climate change
The Trump administration is continuing to pursue its pledge to prioritize American energy independence and scale back the federal government's plans to understand and prevent climate change.
Among other actions, the president has withdrawn the U.S. from the landmark Paris climate agreement.
A key element of his plan is to boost the use of American-sourced fossil fuels such as coal, oil and natural gas, which emit the greenhouse gases that cause climate change.
What can we do?
'We need urgent global action – including the triggering of 'positive tipping points' in our societies and economies – to reach a safe and sustainable future," Lenton said.
As for actions that individuals can take, Lenton said to "eat less meat .... A quarter of all greenhouse gas emissions are linked to diet choices and associated farming practices. It's better for your health as well – most US and European consumers are eating an unhealthy amount of animal protein that increases risk of colorectal cancer, heart disease and diabetes. It's also better for nature – the major cause of net loss of nature worldwide is meat-eating, especially beef as it is a really inefficient way of using land to feed ourselves."
He said individuals can also choose to adopt renewable energy (such as rooftop solar) since the power sector is another quarter of all greenhouse gas emissions.
People can also choose to adopt electric vehicles since road transport is responsible for about 12% of greenhouse gas emissions worldwide, Lenton said.
There is some good news
The study also found that carbon released by certain tipping points (such as Amazon rainforest dieback and permafrost thaw) is unlikely to cause enough warming to trigger other tipping points.
The emissions from those points are not sufficient to trigger what is called a 'tipping cascade," study lead author Jakob Deutloff said, where one tipping element triggers the next one.
'The good news from our study is that the power to prevent climate tipping points is still in our hands,' said Deutloff, also of the University of Exeter. 'By moving toward a more sustainable future with lower emissions, the risk of triggering these tipping points is significantly reduced."
The new study was published April 23 in the journal Earth System Dynamics.
Contributing: Dinah Voyles Pulver, USA TODAY
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Vertex Presents New Data on the Benefits of ALYFTREK
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential. The company shared new data at the 48th European Cystic Fibrosis Conference, revealing that ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) is linked with improved clinical outcomes and quality of life in cystic fibrosis (CF) patients. A pharmacist delivering a specific medication to a patient in a specialty pharmacy. A pooled research found that sweat chloride (SwCl) levels below 60 mmol/L were associated with improved lung function, fewer exacerbations, and better nutritional and quality of life outcomes. Even larger numerical improvements were observed for SwCl below 30 mmol/L. According to post hoc data from Phase 3 trials, ALYFTREK outperformed TRIKAFTA® in terms of health outcomes for adults, adolescents, and children aged 6 to 11. Approximately 109,000 people worldwide, 94,000 of whom live in North America, Europe, and Australia, have cystic fibrosis. The majority of patients have at least one F508del mutation, which is the result of mutations in the CFTR gene. TRIKAFTA® is being donated in 14 lower-income countries, and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) medications currently serve over 75,000 people in 60+ countries, or almost two-thirds of eligible patients. It is among the stocks with the biggest upside. While we acknowledge the potential of VRTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
2 hours ago
- Business Insider
CERo Therapeutics Holdings, Inc. Announces Continued Enhancement of Intellectual Property Portfolio with Two Granted U.S. Patents and European Patent Application Allowance Regarding Company's...
Results in 18 Issued Patents and Allowed Patent Applications Internationally with Nine Total Patent Families SOUTH SAN FRANSCISCO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) ('CERo' or the 'Company') an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that deploy phagocytic (i.e., target-cell eating) mechanisms alongside the array of built-in target cell destroying mechanisms used by T cells, announces two previously announced U.S. patent applications have been granted by the U.S. Patent and Trademark Office (USPTO), and one European patent application has been allowed by the European Patent Office, all of which significantly expand the Company's intellectual property portfolio. The USPTO granted U.S. Patent No. 12,291,557, titled, 'CHIMERIC TIM4 RECEPTORS AND USES THEREOF' on May 6, 2025. The granted claims cover certain design aspects of CER-1236, the Company's lead compound. This patent provides composition of matter protection for a chimeric TIM4 receptor comprising a TIM4 binding domain and canonical T cell signaling domains. Additionally, the European Patent Office has allowed European Patent Application No. 1882166.7 titled, 'CHIMERIC ENGULFMENT RECEPTOR MOLECULES AND METHODS OF USE' on May 16, 2025. The allowed claims encompass a chimeric engulfment receptor comprising a TIM4 binding domain and TLR2 signaling domain. The allowance of this European patent application expands protection of additional design aspects of CER-1236, which have already been granted in the U.S., Japan, and China. Finally, the USPTO granted U.S. Patent No. 12,303,551, titled, 'CELLULAR IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF,' on May 20, 2025. This patent provides coverage for combination cellular immunotherapy compositions and methods of use for CER-1236. The patent covers combination of a chimeric engulfment receptor CD4 + T cell (CD4 + CER-T cell) with a chimeric antigen receptor CD8 + T cell (CD8 + CAR-T cell) or T cell receptor CD8 + T cell (CD8 + TCR-T cell), and their use to treat cancer. This type of combination therapy could be an exciting avenue to complement the CER-T cell technology with other powerful anti-cancer therapies. CERo's intellectual property portfolio now includes 9 total patent families with protection out to 2042 in the United States. With these additional granted patents and allowed application, CER-1236 and its platform technology is supported by 18 total issued patents and allowed patent application internationally. Chris Ehrlich, CERo Therapeutics CEO, commented, 'We continue to aggressively expand our intellectual property portfolio, as it ensures CERo's success in the market. These patents protect the core innovations of the CER-T technology that differentiate it from other cell therapies and demonstrate the true novelty of our design . We continue to seek a robust range of patents across multiple geographies that cover this technology in general, and CER-1236 in particular. The appreciation of the novelty of the CER-T technology by the patent offices validates the innovation and therapeutic potential of this approach, and we believe that we will continue to grow the portfolio. In the near term, we anticipate updates on our clinical trial progress in AML, and the announcement of initiating human trials to treat ovarian and non-small cell lung cancers.' About CERo Therapeutics Holdings, Inc. CERo is an innovative immunotherapy company advancing the development of next generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. This novel cellular immunotherapy platform is expected to redirect patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating what CERo refers to as Chimeric Engulfment Receptor T cells ('CER-T'). CERo believes the differentiated activity of CER-T cells will afford them greater therapeutic application than currently approved chimeric antigen receptor ('CAR-T') cell therapy, as the use of CER-T may potentially span both hematological malignancies and solid tumors. CERo has commenced clinical trials for its lead product candidate CER-1236 for hematological malignancies. This communication contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations of CERo. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this communication, words such as 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' 'strive,' 'would' and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When CERo discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, CERo's management. Actual results could differ from those implied by the forward-looking statements in this communication. Certain risks that could cause actual results to differ are set forth in CERo's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, and the documents incorporated by reference therein. The risks described in CERo's filings with the Securities and Exchange Commission are not exhaustive. New risk factors emerge from time to time, and it is not possible to predict all such risk factors, nor can CERo assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements made by CERo or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. CERo undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Yahoo
6 hours ago
- Yahoo
Experts issue warning as entire staff of critical public information site is abruptly fired: 'I would hate to see it turn into a propaganda website'
One of the internet's most popular sources for climate science abruptly lost nearly all of its staff, The Guardian reported. The cuts to the government-funded site came as the Trump administration has engaged in sweeping efforts to censor climate science and cut funding for climate research. Multiple government workers assigned to the website informed The Guardian that their contracts and those of nearly all of their colleagues had not been renewed as expected. The only workers retained were two web developers, sparking fears that the site, which receives hundreds of thousands of views per month, might not disappear but instead transform into something much worse. "My bigger worry, long-term, is I would hate to see it turn into a propaganda website for this administration, because that's not at all what it was," said Tom Di Liberto, a former spokesperson for the National Oceanic and Atmospheric Administration, the federal agency responsible for the site. Rebecca Lindsey, the website's former program manager, echoed those sentiments, telling The Guardian of the "sinister possibility" that the administration would replace the site's climate science with anti-science propaganda, "leveraging our audience, our brand, our millions of people that we reach on social media every month." "That's the worst case scenario," Lindsey said. For decades, oil, gas, and coal companies — along with their legions of government lobbyists, public-relations experts, and friendly politicians — have led a massive campaign to mislead the public about the devastating impact their products have on the planet, particularly the climate. While disagreements about what to do about climate science are understandable, the Trump administration's censorship of climate science represents the latest iteration of its half-century-long crusade to quell public outrage and quash efforts to build a clean-energy future. Researchers at Columbia Law School put together a comprehensive list of the Trump administration's climate censorship, noting changes to the numerous agency websites, from the Department of Defense to the Department of Energy to the Environmental Protection Agency. The attacks on climate science have not ended with the censorship of government websites. The version of Trump's "Big Beautiful Bill" that passed the House of Representatives cut tax credits aimed at encouraging Americans to invest in renewable energy, electric vehicles, and energy-efficient homes. Do you think misinformation is a major problem in America today? Definitely Only for some people Only with certain issues Not really Click your choice to see results and speak your mind. Perhaps, most significantly, the administration has also taken a hatchet to funding for climate research. In one particularly impactful cut, the administration fired the staff responsible for producing the National Climate Assessment, according to the Natural Resources Defense Council. The only entities that truly stand to benefit from all this are oil and gas companies. "This assessment is so important because it lets every American know how climate change affects their community – or even their own backyard," Ticora Jones, chief science officer at NRDC, said in a statement. "Cutting federal climate research won't eliminate threats from intense heat waves, unprecedented hurricanes, and devastating flooding," she added. "It will just make our nation far less able to prepare for them." With the federal government taking an adversarial approach to climate science, renewable energy, and environmental regulation, it will take a team of other actors working in concert to ensure progression toward a clean-energy future. Those who want to see efforts like these preserved can use their voice by voting for pro-climate candidates and advocating for those in office now to protect these efforts. In addition to advocating for political action, you can make a difference by driving an EV, installing solar panels on your home, or filling your yard with native plants. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
